Health care cost incurred by patients of diabetes mellitus in a tertiary care hospital setting in Coastal Karnataka district

Journal of Global Pharma Technology

Volumn 2, Issue 6, 2010, Pages 8-12

  Sachidananda, Adiga ^a   Lin, Jennie Tan Geok ^b   Usha, Adiga ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

^b MMMC Manipal ^*  (India)

Author keywords

Care cost; Diabets; Health care; Patient

Indexed keywords

ADULT; AGED; ARTICLE; CELLULITIS; CONSULTATION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIABETIC FOOT; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DRUG COST; FEMALE; HEALTH CARE COST; HOSPITAL PATIENT; HUMAN; INDIA; ISCHEMIC HEART DISEASE; LABORATORY; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; RETROSPECTIVE STUDY; TEACHING HOSPITAL; TERTIARY HEALTH CARE; TREATMENT DURATION; URINARY TRACT INFECTION;

EID: 79952676764     PISSN: None     EISSN: 09758542     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ramachandran A., Snehalata C., Kapoor A.,Vijay V., Mohan V.,Das A.K. et al. High prevalence of diabetes and impaired glucose tolerance in India. National Urban Diabetes Survey. Dialectologia. 2001; 44:1094-1101.
2. Ramachandran A., Snehalata C., Latha E., Vijay V., Vishwanathan M. Rising prevalence of NIDDM in urban population in India. Dialectologia. 1997; 40:232-237.
3. Ahuja M.M.S. Epidemiological studies on diabetes mellitus in India. In: Ahuja MMS, editor. Epidemiology of diabetes in developing countries. New Delhi: Interprint; 1979 p29-38.
4. Pradeepa R., Mohan V. The changing scenario of diabetes epidemic implications for India. Indian J. Med. Res.2002; 116:121-32.
5. Kwauja A.K.,Rafique G., White F., Azam S.I. Macrovascular complications and their associated factors among persons with type 2 diabetes in Karachi, Pakisthan- a multicenter study. J. Pak. Med. Assoc. 2004;54(2):60-66.
6. Caro J.J., Ward A.J., and O'Brien J.A. Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care. 2002; 25(3):476-48.
7. Huizinga M.M., Rothman R.L. Addressing the diabetes pandemic: A comprehensive approach. Indian J. Med. Res. 2006; 124:481-4.
8. World Bank. World development Report 1993: Investing in Health World development Indicators. Oxford: Oxford University Press; 1993; 213-214.
9. Shobhana R., Rama Rao P., Lavanya A., Williams A.,Vijay V.,Ramachandran A. Expenditure on health care incurred by diabetes subjects in a developing country: a study from southern India. Diabetes Res. Clin. Prac.2000; 48:37-42.
10. International Diabetes Federation. Diabetes Health Economics: Facts, Figures and Forecasts. Brussels, IDF Task Force on Health economics, 1999; 7-12, 24-27.
11. Shobhana R., Rama Rao P., Lavanya A., Vijay V., Ramachandran A. Cost burden to diabetic patients with foot complications: a study from southern India. J. Assoc. Physicians India.2000; 48:1147-1150.
12. Rayappa P.H., Raju K.N.M., Kapoor A., Bjork S., Sylvest C., Dilipkumar K.M. Economic costs of diabetes care: the Bangalore urban district study diabetes study. Inter. J. Diab Developing Countries.1999; 19: 87-96.
13. Kapoor A., Bjork S., Nair J., Kelkar S., Ramachandran A. Socioeconomic determinants of costs of diabetes in India. Diabetes Voice. 2004; 49: 18-21.
14. Kapoor A. Cost of Diabetes in India-The CODI Study.In: Kapur A, Joshi JK, editor. Proceedings of the Novo Nordisk Diabetes Update, Bangalore: Healthcare Communications LTD; 2000 ;71-7.
15. Lucioni C., Garacini M.P., Massi Benedetti M., Mazzi S., Serra G. The social cost of type 2 diabetes in Italy: the CODE -2 study. Pharmaco. Econo.Ital. Res Artic. 2000; 2:1-21.
16. Kapur A. Economic analysis of diabetes care. Indian J.Med. Res.2007; 125: 473-482.
17. Ramachanran A., Ramachanran S., Chamukuttan S., Augustine C., Murugesan N., Vishwanathan V et al. Increasing expenditure on health care incurred by diabetic subjects in a diabetic subjects in a developing country. Diabetic Care 2007;30 (2): 252-256.